Pro Medicus Competitors

Pro Medicus (ASX:PME) and 1st Group (ASX:1ST) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Valuation and Earnings

This table compares Pro Medicus and 1st Group's gross revenue, earnings per share and valuation.

Pro Medicus has higher revenue and earnings than 1st Group.

Analyst Ratings

This is a summary of current ratings and price targets for Pro Medicus and 1st Group, as provided by MarketBeat.

Profitability

This table compares Pro Medicus and 1st Group's net margins, return on equity and return on assets.

Summary

Pro Medicus beats 1st Group on 3 of the 3 factors compared between the two stocks.

Pro Medicus (ASX:PME) and Alcidion Group (ASX:ALC) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, risk and valuation.

Valuation & Earnings

This table compares Pro Medicus and Alcidion Group's gross revenue, earnings per share and valuation.

Pro Medicus has higher revenue and earnings than Alcidion Group.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Pro Medicus and Alcidion Group, as provided by MarketBeat.com.

Profitability

This table compares Pro Medicus and Alcidion Group's net margins, return on equity and return on assets.

Summary

Pro Medicus beats Alcidion Group on 3 of the 3 factors compared between the two stocks.

Binovi Technologies (OTCMKTS:BNVIF) and Pro Medicus (ASX:PME) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Valuation and Earnings

This table compares Binovi Technologies and Pro Medicus' gross revenue, earnings per share and valuation.

Pro Medicus has higher revenue and earnings than Binovi Technologies.

Profitability

This table compares Binovi Technologies and Pro Medicus' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings for Binovi Technologies and Pro Medicus, as provided by MarketBeat.

Summary

Pro Medicus beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Cann American (CNSX:CNNA) and Pro Medicus (ASX:PME) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership.

Valuation & Earnings

This table compares Cann American and Pro Medicus' revenue, earnings per share and valuation.

Pro Medicus has higher revenue and earnings than Cann American.

Profitability

This table compares Cann American and Pro Medicus' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Cann American and Pro Medicus, as provided by MarketBeat.com.

Summary

Pro Medicus beats Cann American on 1 of the 1 factors compared between the two stocks.

Pro Medicus (ASX:PME) and CannaOne Technologies (OTCMKTS:CNONF) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Profitability

This table compares Pro Medicus and CannaOne Technologies' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and target prices for Pro Medicus and CannaOne Technologies, as reported by MarketBeat.

Valuation and Earnings

This table compares Pro Medicus and CannaOne Technologies' revenue, earnings per share and valuation.

Pro Medicus has higher revenue and earnings than CannaOne Technologies.

Summary

Pro Medicus beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and Pro Medicus (ASX:PME) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Valuation & Earnings

This table compares CloudMD Software & Services and Pro Medicus' top-line revenue, earnings per share (EPS) and valuation.

Pro Medicus has higher revenue and earnings than CloudMD Software & Services.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for CloudMD Software & Services and Pro Medicus, as reported by MarketBeat.com.

CloudMD Software & Services currently has a consensus price target of $3.3750, indicating a potential upside of 110.28%.

Profitability

This table compares CloudMD Software & Services and Pro Medicus' net margins, return on equity and return on assets.